Dollar Rises as Fed Rate Cut Probability Falls to 41%
Dollar strengthens against euro while Fed rate cut probability drops to 41%. Market volatility expected as US economic data resumes post-shutdown. Pound tumbles on UK tax policy shift.
Category : Search result: Sterling Biotech
Sterling Rises Before BoE, NOK Gains on Rate Hold
British Pound strengthens against major currencies ahead of Bank of England policy meeting, while Norwegian Krone climbs as Norway's central bank maintains current interest rates. Market analysis and currency outlook included.
Bharat Biotech enters cell & gene therapy with Nucelion
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
US Push for Affordable Biotech Drugs: India's Opportunity
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
UFC 321: Sterling Doubles Down on Aspinall Eye Poke Claims
The UFC 321 controversy intensifies as Aljamain Sterling stands firm on his explosive comments about Tom Aspinall's eye poke incident. Get the latest on the brewing storm in MMA.
British Pound Plummets to Multi-Month Low vs Dollar
Sterling faces severe pressure as it tumbles to weakest levels in months against USD and hits years-low against EUR. Federal Reserve's hawkish stance and UK economic concerns drive the decline.
Mahomes: Son Picked Our Halloween Costumes
Kansas City Chiefs quarterback Patrick Mahomes shares heartwarming Halloween details about family costumes chosen by his son and wife Brittany's festive leadership in exclusive interview.
CRISPR Therapy Paused After Patient Liver Reaction
In a significant setback for gene editing medicine, Intellia Therapeutics halts its Phase 3 ATTR trial following a serious liver adverse event in a patient receiving CRISPR-based treatment NZ-1.
Novartis Nears $1.7B Avidity Biosciences Acquisition
Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.
Page 2 of 2